Submitted by Anonymous (not verified) on 10 April 2024 - 8:47
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised